Use of pamidronate in the management of acute cancer-related hypercalcemia in children

Med Pediatr Oncol. 1998 Jul;31(1):39. doi: 10.1002/(sici)1096-911x(199807)31:1<39::aid-mpo10>3.0.co;2-y.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Child
  • Diphosphonates / administration & dosage*
  • Diphosphonates / adverse effects
  • Diphosphonates / therapeutic use
  • Humans
  • Hypercalcemia / etiology*
  • Hypercalcemia / therapy*
  • Hypocalcemia / chemically induced
  • Hypophosphatemia / chemically induced
  • Lymphoma, Non-Hodgkin / drug therapy
  • Magnesium / blood
  • Pamidronate

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Magnesium
  • Pamidronate